Advanced liver cancer recurrence rate of 6 into the
Time:2009-11-05 14:45 Author:admin Hits:
Respondents Experts: RUI AN, PLA General Hospital 2nd Affiliated Hospital (formerly 309th Hospital) International Cancer Treatment Center chief physician, enjoying the State Council, special government allowances.
Good treatment: minimally invasive cryosurgical freezing treatment, interventional therapy and bio-immunotherapy liver cancer, liver metastasis of colorectal cancer, pancreatic cancer, stomach cancer, breast cancer, kidney cancer and so on.
Outpatient Hours: Monday (AM).
Tel: (010) 51,520,412.
Due to liver tumor size, growth, location, and with the large blood vessels, the relationship between biliary tract location restrictions, some of the more unique small liver cancer, a huge liver tumor with multiple metastatic lesions in patients with advanced hepatocellular carcinoma, often lost the chance of operation.
However, for such patients, the PLA General Hospital 2nd Affiliated Hospital (formerly 309th Hospital) The International Cancer Treatment Center, Professor RUI AN treatment methods, first with argon-helium ultra-cold knife minimally invasive treatment, by physical means in the short term freeze-thaw destroy the cell structure of tumor tissue, prompting closure of tumor necrosis and small blood vessels in tumors. At the same time combined interventional therapy, the tumor grows locally high concentrations of blood clots with chemotherapy, and two kinds of therapies in combination in the short term inhibition of liver cancer cell growth, the eradication of tumor lesions.
In general, the majority of primary liver cancer is unresectable large liver, accompanied by extrahepatic portal venous system thrombosis, radiotherapy and chemotherapy after a year recurrence rate of up to 60%, 3-year survival rate of less than 30%. Therefore, the liver is most important is to prevent postoperative recurrence, but the traditional radiotherapy and chemotherapy side effects large, easily lead to cirrhosis and even liver damage.
At present, the relatively new treatment --- biological cell-mediated immunity (CIK cells) for advanced liver cancer significantly, this therapy can help clear the remnants of cancer patients is to restore patients to identify, to kill cancer cells immune function, and thus to prevent and control of tumor metastasis. CIK cells are cytokine-induced killer cells from peripheral blood, bone marrow or umbilical cord blood mononuclear cells were isolated, after a certain period of time a laboratory induction, proliferation, come back to the patient directly to kill the present in blood, lymph in the tumor cells, while regulating and enhancing the patient's immune function.
The clinical statistics, nine cases of four patients with hepatocellular carcinoma after three cycles of postoperative immune therapy, may be better to prevent postoperative recurrence of hepatocellular carcinoma. After treatment the average survival period of 20 months, 1 year recurrence rate is only 22.2%, the majority of patients with symptoms can be improved.
Good treatment: minimally invasive cryosurgical freezing treatment, interventional therapy and bio-immunotherapy liver cancer, liver metastasis of colorectal cancer, pancreatic cancer, stomach cancer, breast cancer, kidney cancer and so on.
Outpatient Hours: Monday (AM).
Tel: (010) 51,520,412.
Due to liver tumor size, growth, location, and with the large blood vessels, the relationship between biliary tract location restrictions, some of the more unique small liver cancer, a huge liver tumor with multiple metastatic lesions in patients with advanced hepatocellular carcinoma, often lost the chance of operation.
However, for such patients, the PLA General Hospital 2nd Affiliated Hospital (formerly 309th Hospital) The International Cancer Treatment Center, Professor RUI AN treatment methods, first with argon-helium ultra-cold knife minimally invasive treatment, by physical means in the short term freeze-thaw destroy the cell structure of tumor tissue, prompting closure of tumor necrosis and small blood vessels in tumors. At the same time combined interventional therapy, the tumor grows locally high concentrations of blood clots with chemotherapy, and two kinds of therapies in combination in the short term inhibition of liver cancer cell growth, the eradication of tumor lesions.
In general, the majority of primary liver cancer is unresectable large liver, accompanied by extrahepatic portal venous system thrombosis, radiotherapy and chemotherapy after a year recurrence rate of up to 60%, 3-year survival rate of less than 30%. Therefore, the liver is most important is to prevent postoperative recurrence, but the traditional radiotherapy and chemotherapy side effects large, easily lead to cirrhosis and even liver damage.
At present, the relatively new treatment --- biological cell-mediated immunity (CIK cells) for advanced liver cancer significantly, this therapy can help clear the remnants of cancer patients is to restore patients to identify, to kill cancer cells immune function, and thus to prevent and control of tumor metastasis. CIK cells are cytokine-induced killer cells from peripheral blood, bone marrow or umbilical cord blood mononuclear cells were isolated, after a certain period of time a laboratory induction, proliferation, come back to the patient directly to kill the present in blood, lymph in the tumor cells, while regulating and enhancing the patient's immune function.
The clinical statistics, nine cases of four patients with hepatocellular carcinoma after three cycles of postoperative immune therapy, may be better to prevent postoperative recurrence of hepatocellular carcinoma. After treatment the average survival period of 20 months, 1 year recurrence rate is only 22.2%, the majority of patients with symptoms can be improved.
